The ReSurge trial could achieve an increasing recruitment rate during the last year. This is great, especially in view of the pandemia which accompanies us for over a year now. We’d like to thank all trial teams from all centers for their effort and persistance. We count now 59 patients from a total of 27…
Read more
Also the newly opened sites in Larisa, Erfurt and Mainz could recuit their first patient. Moreover, one more patient was recruited in Lausanne and six in Bern.In total 36 patients are participating in the trial.
We very welcome Universitair Medische Centra in Amsterdam with their principal investigator Dr. Philip de Witt Hamer to the ReSurge trial team. Not long after recruitment start, the first patient was included into the RCT group – congratulations!
We very welcome to the ReSurge community the clinical investigation center of the University Hospital of Lisboa and the Neurosurgery division of the University Hospital of Alberta, Canada.
Congratulations to the Site Lausanne on including another patient this week! A total of 20 patients are now part of the trial.
This week we included the 13th patient in Bern. This means 19 patients in total are part of the trial.
On April 4th the Resurge Team in Lugano included their first Patient in the Trial. Congratulations!
We are very happy to welcome the Trial Teams in Giessen, Mainz and Erfurt on board the Resurge Study. Giessen Mainz Erfurt
On January 26th the Resurge Team in Basel included their first Patient in the Trial. Congratulations!